Krystal Biotech, Inc. (KRYS) Tops Q3 EPS by $1.57
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Join SI Premium – FREE
Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q3 EPS of $2.66, $1.57 better than the analyst estimate of $1.09. Revenue for the quarter came in at $97.8 million versus the consensus estimate of $93.19 million.
For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Workhorse Group (WKHS) Misses Q2 EPS by 77c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
